Conversely, a preclinical model has demonstrated that GATA6 knockout augmented T cell-mediated tumor cell killing,27 and a negative correlation was observed between GATA6 and the T cell activator PD-L1.26 The gene discussed is GATA6; the disease is neoplasm.